共 50 条
Transforming Growth Factor β Depletion Is the Primary Determinant of Smad Signaling Kinetics
被引:51
|作者:
Clarke, David C.
[1
,2
]
Brown, Meredith L.
[1
]
Erickson, Richard A.
[1
]
Shi, Yigong
[3
]
Liu, Xuedong
[1
]
机构:
[1] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA
[2] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA
[3] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
基金:
美国国家卫生研究院;
关键词:
BMP ACTIVITY GRADIENT;
TGF-BETA;
MORPHOGEN GRADIENT;
MEDIATED ENDOCYTOSIS;
TUMOR-SUPPRESSOR;
XENOPUS CELLS;
RECEPTOR;
PROTEIN;
TRANSDUCTION;
ACTIVIN;
D O I:
10.1128/MCB.01443-08
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
A cell's decision to growth arrest, apoptose, or differentiate in response to transforming growth factor beta (TGF-beta) superfamily ligands depends on the ligand concentration. How cells sense the concentration of extracellular bioavailable TGF-beta remains poorly understood. We therefore undertook a systematic quantitative analysis of how TGF-beta ligand concentration is transduced into downstream phospho-Smad2 kinetics, and we found that the rate of TGF-beta ligand depletion is the principal determinant of Smad signal duration. TGF-beta depletion is caused by two mechanisms: (i) cellular uptake of TGF-beta by a TGF-beta type II receptor-dependent mechanism and (ii) reversible binding of TGF-beta to the cell surface. Our results indicate that cells sense TGF-beta dose by depleting TGF-beta via constitutive TGF-beta type II receptor trafficking processes. Our results also have implications for the role of the TGF-beta type II receptor in disease, as tumor cells harboring TGF-beta type II receptor mutations exhibit impaired TGF-beta depletion, which may contribute to the overproduction of TGF-beta and a consequently poor prognosis in cancer.
引用
收藏
页码:2443 / 2455
页数:13
相关论文